(Q30879681)

27 June 2017

0 references

1 reference

title

Remacemide for drug-resistant localization related epilepsy (English)

1 reference

27 June 2017

J P Leach

1

1 reference

27 June 2017

A G Marson

series ordinal

2

1 reference

27 June 2017

J L Hutton

series ordinal

3

1 reference

27 June 2017

publication date

1 January 2002

1 reference

Cochrane Database of Systematic Reviews

27 June 2017

published in

1 reference

27 June 2017

issue

4

1 reference

27 June 2017

page(s)

CD001900

1 reference

Remission of epilepsy: results from the National General Practice Study of Epilepsy.

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001900

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001900

Preclinical profile of the anticonvulsant remacemide and its enantiomers in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001900

Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001900

Topiramate add-on for drug-resistant partial epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001900

Lamotrigine add-on for drug-resistant partial epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001900

Epidemiology of the epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001900

Adjustment of carbamazepine dose to offset the effects of the interaction with remacemide hydrochloride in a double-blind, multicentre, add-on drug trial (CR2237) in refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001900

A placebo-controlled, double-blind cross-over trial of adjunctive one month remacemide hydrochloride treatment in patients with refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001900

Neuropsychological outcomes in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001900

10.1002/14651858.CD001900

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference